PAREXEL International PT Raised to $58.00 at Jefferies Group (PRXL)
Analysts at Jefferies Group upped their target price on shares of PAREXEL International (NASDAQ:PRXL) from $53.00 to $58.00 in a research report issued to clients and investors on Tuesday. Jefferies Group’s target price would indicate a potential upside of 8.07% from the stock’s previous close.
PAREXEL International (NASDAQ:PRXL) traded up 0.79% during mid-day trading on Tuesday, hitting $53.67. 440,963 shares of the company’s stock traded hands. PAREXEL International has a 52-week low of $37.53 and a 52-week high of $57.25. The stock has a 50-day moving average of $49.12 and a 200-day moving average of $49.19. The company has a market cap of $3.052 billion and a price-to-earnings ratio of 25.80.
PAREXEL International (NASDAQ:PRXL) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.02. The company had revenue of $492.40 million for the quarter, compared to the consensus estimate of $493.35 million. During the same quarter in the previous year, the company posted $0.50 earnings per share. The company’s revenue for the quarter was up 8.3% on a year-over-year basis. Analysts expect that PAREXEL International will post $2.13 EPS for the current fiscal year.
In other PAREXEL International news, Director Patrick J. Fortune unloaded 3,000 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $53.04, for a total transaction of $159,120.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
PRXL has been the subject of a number of other recent research reports. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of PAREXEL International in a research note on Tuesday. They now have a $61.00 price target on the stock, up previously from $57.00. Separately, analysts at ISI Group downgraded shares of PAREXEL International from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 11th. They noted that the move was a valuation call. Finally, analysts at Raymond James initiated coverage on shares of PAREXEL International in a research note on Friday, May 30th. They set a “market perform” rating on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company’s stock. PAREXEL International currently has an average rating of “Hold” and a consensus price target of $52.14.
PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.